nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Active management of mild obstructive sleep apnoea: the evidence grows
|
McNicholas, Walter T |
|
|
8 |
4 |
p. 322-323 |
artikel |
2 |
Adoption of COVID-19 triage strategies for low-income settings
|
Ayebare, Rodgers R |
|
|
8 |
4 |
p. e22 |
artikel |
3 |
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
|
Fang, Lei |
|
|
8 |
4 |
p. e21 |
artikel |
4 |
Blood transcriptional biomarkers for active pulmonary tuberculosis in a high-burden setting: a prospective, observational, diagnostic accuracy study
|
Turner, Carolin T |
|
|
8 |
4 |
p. 407-419 |
artikel |
5 |
Blood transcriptional signatures for tuberculosis testing
|
Mendelsohn, Simon C |
|
|
8 |
4 |
p. 330-331 |
artikel |
6 |
Concise whole blood transcriptional signatures for incipient tuberculosis: a systematic review and patient-level pooled meta-analysis
|
Gupta, Rishi K |
|
|
8 |
4 |
p. 395-406 |
artikel |
7 |
Continuous positive airway pressure versus standard care for the treatment of people with mild obstructive sleep apnoea (MERGE): a multicentre, randomised controlled trial
|
Wimms, Alison J |
|
|
8 |
4 |
p. 349-358 |
artikel |
8 |
Correction to Lancet Respir Med 2020; 8: 420–22
|
|
|
|
8 |
4 |
p. e26 |
artikel |
9 |
Correction to Lancet Respir Med 2020; 8: e20
|
|
|
|
8 |
4 |
p. e26 |
artikel |
10 |
Correction to Lancet Respir Med 2020; published online Feb 21. https://doi.org/10.1016/S2213-2600(20)30079-5
|
|
|
|
8 |
4 |
p. e26 |
artikel |
11 |
COVID-19: delay, mitigate, and communicate
|
The Lancet Respiratory Medicine, |
|
|
8 |
4 |
p. 321 |
artikel |
12 |
COVID-19, ECMO, and lymphopenia: a word of caution
|
Henry, Brandon Michael |
|
|
8 |
4 |
p. e24 |
artikel |
13 |
COVID-19: the need for continuous medical education and training
|
Li, Li |
|
|
8 |
4 |
p. e23 |
artikel |
14 |
Cystic fibrosis in Turkey
|
Dogru, Deniz |
|
|
8 |
4 |
p. e17 |
artikel |
15 |
Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis
|
Lan, Zhiyi |
|
|
8 |
4 |
p. 383-394 |
artikel |
16 |
Effect of obstructive sleep apnoea and its treatment with continuous positive airway pressure on the prevalence of cardiovascular events in patients with acute coronary syndrome (ISAACC study): a randomised controlled trial
|
Sánchez-de-la-Torre, Manuel |
|
|
8 |
4 |
p. 359-367 |
artikel |
17 |
Evolving therapies for rifampicin-resistant tuberculosis: balancing efficacy and toxicity
|
Variava, Ebrahim |
|
|
8 |
4 |
p. 326-328 |
artikel |
18 |
Gag clause prevents discussion of assisted dying in Victoria, Australia
|
Kirby, Tony |
|
|
8 |
4 |
p. 341-342 |
artikel |
19 |
Headway made towards biosignatures for incipient tuberculosis
|
Scriba, Thomas J |
|
|
8 |
4 |
p. 328-330 |
artikel |
20 |
Host-directed therapies and holistic care for tuberculosis
|
Zumla, Alimuddin |
|
|
8 |
4 |
p. 337-340 |
artikel |
21 |
Interstitial lung diseases: a call for papers
|
Grainger, Emma |
|
|
8 |
4 |
p. 340 |
artikel |
22 |
Obstructive sleep apnoea in acute coronary syndrome
|
Peker, Yüksel |
|
|
8 |
4 |
p. e14 |
artikel |
23 |
Obstructive sleep apnoea in acute coronary syndrome
|
Martinez-Garcia, Miguel A |
|
|
8 |
4 |
p. e15 |
artikel |
24 |
Obstructive sleep apnoea in acute coronary syndrome – Authors' reply
|
Sánchez-de-la-Torre, Manuel |
|
|
8 |
4 |
p. e16 |
artikel |
25 |
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
|
Xu, Zhe |
|
|
8 |
4 |
p. 420-422 |
artikel |
26 |
Patient support is vital to treatment adherence
|
Soe, Kyi Pyar |
|
|
8 |
4 |
p. 346 |
artikel |
27 |
Post-tuberculosis mortality and morbidity: valuing the hidden epidemic
|
Quaife, Matthew |
|
|
8 |
4 |
p. 332-333 |
artikel |
28 |
Programmatic versus personalised approaches to managing the global epidemic of multidrug-resistant tuberculosis
|
Chakaya, Jeremiah Muhwa |
|
|
8 |
4 |
p. 334-335 |
artikel |
29 |
Respiratory support for patients with COVID-19 infection
|
Ñamendys-Silva, Silvio A |
|
|
8 |
4 |
p. e18 |
artikel |
30 |
Sex difference and smoking predisposition in patients with COVID-19
|
Cai, Hua |
|
|
8 |
4 |
p. e20 |
artikel |
31 |
Speaking from the head and the heart
|
Morgan, Jules |
|
|
8 |
4 |
p. 347-348 |
artikel |
32 |
Staff safety during emergency airway management for COVID-19 in Hong Kong
|
Cheung, Jonathan Chun-Hei |
|
|
8 |
4 |
p. e19 |
artikel |
33 |
The role of policy in the EVALI outbreak: solution or contributor?
|
Smith, Danielle M |
|
|
8 |
4 |
p. 343-344 |
artikel |
34 |
Time to rename COPD exacerbations: implementing the term lung attack
|
Holverda, Sebastiaan |
|
|
8 |
4 |
p. e25 |
artikel |
35 |
Treatment for obstructive sleep apnoea and cardiovascular diseases: are we aiming at the wrong target?
|
Heinzer, Raphael |
|
|
8 |
4 |
p. 323-325 |
artikel |
36 |
Tuberculosis in children, adolescents, and women
|
Marais, Ben J |
|
|
8 |
4 |
p. 335-337 |
artikel |
37 |
Unmasked: we all breathe
|
Burki, Talha Khan |
|
|
8 |
4 |
p. 348 |
artikel |
38 |
Where next for inhaled corticosteroids in childhood asthma?
|
Sinha, Ian P |
|
|
8 |
4 |
p. 345 |
artikel |
39 |
Xpert MTB/RIF Ultra and Xpert MTB/RIF for diagnosis of tuberculosis in an HIV-endemic setting with a high burden of previous tuberculosis: a two-cohort diagnostic accuracy study
|
Mishra, Hridesh |
|
|
8 |
4 |
p. 368-382 |
artikel |
40 |
Xpert MTB/RIF Ultra: what is the real impact?
|
Bonnet, Maryline |
|
|
8 |
4 |
p. 325-326 |
artikel |